SPONSOR
Zhejiang University
Total Trials
7
Recruiting
7
Phases
Phase 2, EARLY_Phase 1, Phase 3
Conditions studied: Metastatic Pancreatic CarcinomaAcute Myeloid LeukemiaColorectal CancerAdenomatous PolypsAdenomaAdvanced AdenomaAcute Lymphoblastic LeukemiaNon-Hodgkin Lymphoma of Soft TissueCholedocholithiasis With Cholecystitis With ObstructionObstructive Jaundice
Zhejiang University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Metastatic Pancreatic Carcinoma, Acute Myeloid Leukemia, Colorectal Cancer, Adenomatous Polyps.
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhejiang University
How many clinical trials has Zhejiang University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Zhejiang University, of which 7 are actively recruiting participants. These trials cover conditions including Metastatic Pancreatic Carcinoma, Acute Myeloid Leukemia, Colorectal Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhejiang University research focus on?
Zhejiang University clinical trials span Metastatic Pancreatic Carcinoma, Acute Myeloid Leukemia, Colorectal Cancer, Adenomatous Polyps, Adenoma, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhejiang University clinical trial?
To participate in a Zhejiang University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhejiang University trials with current recruitment status updated daily.
Clinical Trials by Zhejiang University
NCT06770452 Phase 2
Recruiting
HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
Metastatic Pancreatic Carcinoma
NCT06762132 EARLY_Phase 1
Recruiting
A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
NCT06220617
Recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
Colorectal Cancer
NCT04532281 EARLY_Phase 1
Recruiting
A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies
Acute Lymphoblastic Leukemia
NCT07012772 Phase 2
Recruiting
COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
Choledocholithiasis With Cholecystitis With Obstruction
NCT07359586
Recruiting
Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
Gastric Cancer
NCT05593458 Phase 3
Recruiting
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
Locally Advanced Gastric Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology